Global disparities in pediatric type 1 diabetes management persist despite standardized care principles, with economic factors influencing technology access, glycemic targets, and acute complication rates. The SWEET international registry provides real-world benchmarking across diverse healthcare systems. 
In the study published in the Diabetes Research and Clinical Practice, the investigators conducted cross-sectional analysis of 54,285 individuals under age 25 years with type 1 diabetes duration exceeding three months from 130 centers spanning 2022-2023, stratifying centers by national gross domestic product quartiles. Primary outcomes encompassed technology utilization (insulin pumps, continuous glucose monitoring, automated insulin delivery, rapid-acting insulin analogs), screening rates for comorbidities, HbA1c, body mass index standard deviation scores, diabetic ketoacidosis episodes, and severe hypoglycemia events per 100 patient-years.
Technology Gradient Parallels Economic Status
Insulin pump utilization ranged from 17.4% in lowest GDP quartile to 70.2% in highest, continuous glucose monitoring from 36.2% to 91.5%, automated insulin delivery from 11.2% to 38.2%, and rapid-acting analog use from 56.9% to 78.2%. Higher GDP consistently correlated with advanced technology penetration, facilitating tighter glycemic control.
Non-Linear HbA1c Pattern Emerges
HbA1c demonstrated U-shaped distribution across quartiles: 8.74% (lowest GDP), 7.50% (lower-middle), 7.66% (upper-middle), and 8.18% (highest). Middle-income centers achieved superior glycemic control, potentially reflecting optimized resource allocation balancing technology access with intensive management protocols.
Complication Rates Vary Systematically
Severe hypoglycemia declined from 9.6 to 1.3 events per 100 patient-years across increasing GDP quartiles, while diabetic ketoacidosis followed non-monotonic pattern peaking at 3.10 events per 100 patient-years in highest GDP group versus nadir of 0.90 in lower-middle. Comorbidity screening rates maximized in middle quartiles.
Body Composition Tracks Economic Development
BMI standard deviation scores progressed from +0.04 in lowest GDP to +0.89 in highest quartile, paralleling overweight prevalence and nutritional transition patterns.
Resource Allocation Lessons for Global T1D Care
Pediatric endocrinologists recognize middle-income systems achieving optimal HbA1c through efficient technology deployment and screening infrastructure, challenging assumptions that highest GDP equates superior outcomes. High-income centers face DKA uptrends potentially linked to over-reliance on technology without behavioral reinforcement. These findings advocate targeted knowledge transfer from middle-income models to optimize global pediatric type 1 diabetes care equity.